-
Yahoo Finance Video • 14 hours ago
BMY CELG-RT AON -
- AI infrastructure plays are the way to go: Analyst The tech sector is pulling stock markets (^DJI, ^IXIC, ^GSPC) lower following underwhelming reports from Magnificent Seven tech stocks. Harvest Portfolio Management CIO and partner Paul Meeks comes on Catalysts to share his perspective on the current market rotations. Meeks reveals he's refraining from buying tech stocks at the moment. While he remains "pretty comfortable with the continued AI infrastructure building names," he acknowledges that regardless of fundamental performance, stock prices could still decline. "So what I am doing is I have a prohibition on buying [tech stocks] at least till we get through next week's reports," he explains. In terms of specific investments, Meeks highlights several AI infrastructure plays, including Nvidia (NVDA), Advanced Micro Devices (AMD), Dell (DELL), Hewlett Packard Enterprise (HPE), and Super Micro Computer (SMCI). However, for other AI-related companies, he emphasizes the need to see "more use cases" before gaining confidence in investing. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Angel Smith
Yahoo Finance Video • 19 hours ago
HPE NVDA SMCI -
Yahoo Finance Video • 21 hours ago
AVGO QCOM TXN - Charter Communications Q2 Sees Subscriber Loss On ACC Expiry, Still Beats Expectations Charter Communications Inc (NASDAQ:CHTR) reported fiscal second-quarter 2024 revenue growth of 0.2% year-on-year to $13.69 billion, beating the analyst consensus estimate of $13.59 billion. EPS of $8.49 beat the analyst consensus estimate of $7.95. The stock price gained after the results. Revenue growth of 1.3% in Internet, 36.9% in Mobile service, and 2.1% in Commercial aided the top line. Charter lost 154,000 residential Internet customers, largely driven by the end of the FCC's Affordable Co
Benzinga • 7 minutes ago
CHTR - Colgate-Palmolive raises 2024 forecasts on strong demand Toothpaste maker Colgate-Palmolive raised its forecasts for annual profit and organic sales on Friday, after beating second-quarter estimates on resilient demand for its high-priced products. WHY IT'S IMPORTANT Organic sales in the Latin American segment - a major revenue-generating region - jumped 18.8% in the quarter, compared with a 16% rise a year earlier. Increased investments in advertising also helped the company counter rising competition from lower-priced private labels.
Reuters • 13 minutes ago
See AlsoUltrack Systems, Inc. (MJLB) Stock Historical Prices & Data - Yahoo FinanceAmarin Corporation plc (AMRN) Price & News - Google FinanceCL -
- Dow Jones Futures Rise As Nvidia Fights AI Fatigue; Fed's Inflation Data Due Small caps jumped as the Nasdaq and Nvidia fight AI fatigue. ServiceNow broke out. The Fed's key inflation gauge is due.
Investor's Business Daily • 20 minutes ago
NVDA COMP ^GSPC -
Benzinga • 29 minutes ago
CELG-RT - Is Eli Lilly Stock A Sell On A Second Stumble In Obesity Treatment? Is Eli Lilly stock a sell after new rivals emerged from the woodwork with promising test results and plans for oral obesity drugs?
Investor's Business Daily • 37 minutes ago
LLY NVO BIIB - Everi Holdings, International Game Technology Sign $6.30 Billion Acquisition Deal With Apollo Global Management Funds Everi Holdings, International Game Technology Sign $6.30 Billion Acquisition Deal With Apollo Global Management Funds
PREMIUM
MT Newswires • 1 hour ago
IGT EVRI APO-PA -
- 5 Things to Know Before the Stock Market Opens News of the day for July 26, 2024
Investopedia • 1 hour ago
AAPL DECK - These Stocks Are Moving the Most Today: DexCom, Deckers, Ford, Nvidia, Alphabet, 3M, Coursera, Bristol Myers, and More DexCom falls sharply after cutting its fiscal-year sales forecast, Deckers Outdoor jumps after raising earnings expectations, and 3M posts better-than-forecast earnings.
Barrons.com • 1 hour ago
GOOG DXCM F - Bristol Myers Stock Jumps. A Sales Jump for Eliquis Boosts Earnings. Global sales of Eliquis, a drug used to reduce the risk of stroke and blood clots, increase 7% in the second quarter from a year earlier.
Barrons.com • 1 hour ago
CELG-RT - Update on Regulatory Review of Lecanemabfor Early Alzheimer’s Disease in the European Union TOKYO and CAMBRIDGE, Mass., July 26, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the Marketing Authorization Approval (MAA) for the humanized anti-soluble aggregated amyloid-beta
GlobeNewswire • 1 hour ago
BIIB -
- Colgate Stock Is Rising After Earnings. Here’s Why. The consumer products company reports second-quarter adjusted earnings of 91 cents a share, beating Wall Street estimates of 87 cents.
Barrons.com • 1 hour ago
CL - Charter's (NASDAQ:CHTR) Q2 Earnings Results: Revenue In Line With Expectations, Stock Jumps 11.1% Cable, internet, and telephone services provider Charter (NASDAQ:CHTR) reported results in line with analysts' expectations in Q2 CY2024, with revenue flat year on year at $13.69 billion. It made a GAAP profit of $8.49 per share, improving from its profit of $8.05 per share in the same quarter last year.
StockStory • 1 hour ago
CHTR - Could Investing in AMD Now Be Like Investing in Nvidia in 2023? AMD has been lagging behind Nvidia for some time.
Motley Fool • 1 hour ago
NVDA AMD - Bristol Myers Squibb Earnings Easily Beat On Cost Cuts; Stock Jumps Bristol Myers Squibb earnings easily topped Q2 views, fueled by cost cuts and blockbuster drug Eliquis. Bristol Myers stock jumped.
Investor's Business Daily • 1 hour ago
CELG-RT -
- Newell Brands: Q2 Earnings Snapshot The Atlanta-based company said it had net income of 11 cents per share. Earnings, adjusted for costs related to mergers and acquisitions and restructuring costs, came to 36 cents per share. The results exceeded Wall Street expectations.
Associated Press Finance • 1 hour ago
NWL - Apollo Funds to take IGT Gaming, Everi private in $6.3 billion deal (Reuters) -Private equity firm Apollo Funds will take International Game Technology's gaming and digital business and Everi Holdings private in an all-cash deal that values the combined business at $6.3 billion, the companies said on Friday. Shares of IGT jumped 16%, while casino platform provider Everi rose 38% in premarket trading. The deal is the latest sign of a resurgence in the private equity space following a period of dormancy due to high interest rates that had hindered debt financing for leveraged buyouts.
Reuters • 1 hour ago
IGT EVRI - Colgate-Palmolive's (NYSE:CL) Q2: Beats On Revenue Consumer products company Colgate-Palmolive (NYSE:CL) reported Q2 CY2024 results topping analysts' expectations, with revenue up 4.9% year on year to $5.06 billion. It made a non-GAAP profit of $0.91 per share, improving from its profit of $0.77 per share in the same quarter last year.
StockStory • 1 hour ago
CL
